Building a Pharmacological Lexicon: Small Molecule Discovery in Academia

Small molecules are powerful pharmacological tools to dissect biological events. There is now considerable interest in expanding efforts to identify and use small molecules targeting proteins encoded in the genomes of humans and pathogenic organisms. Integration of the principles of molecular pharmacology with contemporary high-throughput and high-content screening technologies is essential for the success of these discovery activities. We present some of the challenges and opportunities provided by the Molecular Library Screening Centers Network (MLSCN), which is a National Institutes of Health Roadmap Initiative.

[1]  L. Roberts.  Plan for genome centers sparks a controversy. , 1989, Science.

[2]  D. Tindall,et al.  CDK2-Dependent Phosphorylation of FOXO1 as an Apoptotic Response to DNA Damage , 2006, Science.

[3]  Bernard H. Munos,et al.  Can open-source R&D reinvigorate drug research? , 2006, Nature Reviews Drug Discovery.

[4]  J. Lazo.  Roadmap or roadkill: a pharmacologist's analysis of the NIH Molecular Libraries Initiative. , 2006, Molecular interventions.

[5]  C. Behl,et al.  Cholesterol-Like Effects of Selective Cyclooxygenase Inhibitors and Fibrates on Cellular Membranes and Amyloid-β Production , 2007, Molecular Pharmacology.

[6]  Planning science (a generation after Lewis Thomas). , 2006, The Journal of clinical investigation.

[7]  Adam Yasgar,et al.  Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Eva J Gordon.  Small-molecule screening: it takes a village... , 2007, ACS chemical biology.

[9]  Ian Parker,et al.  Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo , 2006, Nature chemical biology.

[10]  S. Korsmeyer,et al.  An inhibitor of Bcl-2 family proteins induces regression of solid tumours , 2005, Nature.

[11]  S. Winchester.  The Professor and the Madman , 1998 .

[12]  A. Marks.  Rescuing the NIH before it is too late. , 2006, The Journal of clinical investigation.

[13]  P. Deng,et al.  Serotonin Inhibits Neuronal Excitability by Activating Two-Pore Domain K+ Channels in the Entorhinal Cortex , 2007, Molecular Pharmacology.